Yann Lécluse

5.7k total citations
58 papers, 2.7k citations indexed

About

Yann Lécluse is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yann Lécluse has authored 58 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 17 papers in Oncology and 17 papers in Immunology. Recurrent topics in Yann Lécluse's work include Immune Cell Function and Interaction (8 papers), Immunotherapy and Immune Responses (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). Yann Lécluse is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Immunotherapy and Immune Responses (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). Yann Lécluse collaborates with scholars based in France, United States and Morocco. Yann Lécluse's co-authors include William Vainchenker, Frédéric Larbret, Salem Chouaı̈b, Valérie Ugo, Najet Debili, Fathia Mami‐Chouaib, Irène Teyssandier, Nicole Casadevall, Chloé James and Isabelle Godin and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Yann Lécluse

58 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yann Lécluse France	33	1.5k	698	641	594	582	58	2.7k
Hideyo Hirai Japan	33	1.4k 1.0×	794 1.1×	792 1.2×	1.4k 2.3×	402 0.7×	105	3.4k
Chris Saris United States	19	1.5k 1.1×	763 1.1×	926 1.4×	881 1.5×	332 0.6×	25	3.3k
H. Scott Boswell United States	29	1.6k 1.1×	1.1k 1.6×	594 0.9×	1.2k 2.1×	540 0.9×	63	3.6k
Eric H. Westin United States	28	2.2k 1.5×	462 0.7×	819 1.3×	759 1.3×	379 0.7×	66	3.6k
Marc A. Kerenyi United States	20	1.3k 0.9×	553 0.8×	494 0.8×	863 1.5×	454 0.8×	27	2.4k
Shinobu Tsuzuki Japan	28	1.7k 1.2×	688 1.0×	656 1.0×	560 0.9×	338 0.6×	86	3.1k
Tetsuya Yamagata Japan	25	1.2k 0.8×	618 0.9×	499 0.8×	1.1k 1.8×	228 0.4×	58	2.7k
Blanca Scheijen Netherlands	24	1.5k 1.0×	566 0.8×	615 1.0×	311 0.5×	282 0.5×	53	2.6k
Mathijs Baens Belgium	29	1.5k 1.0×	742 1.1×	959 1.5×	1.2k 2.0×	595 1.0×	51	3.7k
Norihiko Kawamata Japan	38	2.2k 1.5×	745 1.1×	1.4k 2.1×	467 0.8×	610 1.0×	96	4.0k

Countries citing papers authored by Yann Lécluse

Since Specialization

Citations

This map shows the geographic impact of Yann Lécluse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yann Lécluse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yann Lécluse more than expected).

Fields of papers citing papers by Yann Lécluse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yann Lécluse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yann Lécluse. The network helps show where Yann Lécluse may publish in the future.

Co-authorship network of co-authors of Yann Lécluse

This figure shows the co-authorship network connecting the top 25 collaborators of Yann Lécluse. A scholar is included among the top collaborators of Yann Lécluse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yann Lécluse. Yann Lécluse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mezquita, Laura, Marianne Oulhen, Marc Deloger, et al.. (2024). Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer. British Journal of Cancer. 130(4). 682–693. 1 indexed citations

Allouch, Awatef, Laurent Voisin, Yanyan Zhang, et al.. (2022). CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia. Nature Communications. 13(1). 6739–6739. 10 indexed citations

Oulhen, Marianne, Patrycja Pawlikowska, Genny Buson, et al.. (2021). Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors. npj Precision Oncology. 5(1). 67–67. 17 indexed citations

Wang, Shoutang, Yann Lécluse, Dominik Filipp, et al.. (2021). Lyl-1 regulates primitive macrophages and microglia development. Communications Biology. 4(1). 1382–1382. 9 indexed citations

Della-Valle, Véronique, Damien Roos‐Weil, Laurianne Scourzic, et al.. (2020). Nfkbie-deficiency leads to increased susceptibility to develop B-cell lymphoproliferative disorders in aged mice. Blood Cancer Journal. 10(3). 38–38. 10 indexed citations

Pailler, Emma, Vincent Faugeroux, Marianne Oulhen, et al.. (2019). Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in ALK -Rearranged Non–Small-Cell Lung Cancer. Clinical Cancer Research. 25(22). 6671–6682. 92 indexed citations

Camara‐Clayette, Valérie, Yann Lécluse, Christoph Schrader, et al.. (2013). The NF-κB pathway is rarely spontaneously activated in mantle cell lymphoma (MCL) cell lines and patient’s samples. European Journal of Cancer. 50(1). 159–169. 4 indexed citations

Capron, Claude, Catherine Lacout, Yann Lécluse, et al.. (2010). A major role of TGF-β1 in the homing capacities of murine hematopoietic stem cell/progenitors. Blood. 116(8). 1244–1253. 31 indexed citations

Mori, Marcella, Thierry Langlois, Frédéric Larbret, et al.. (2009). A common bipotent progenitor generates the erythroid and megakaryocyte lineages in embryonic stem cell–derived primitive hematopoiesis. Blood. 114(8). 1506–1517. 110 indexed citations

10.

Noman, Muhammad Zaeem, Stéphanie Buart, Jos van Pelt, et al.. (2009). The Cooperative Induction of Hypoxia-Inducible Factor-1α and STAT3 during Hypoxia Induced an Impairment of Tumor Susceptibility to CTL-Mediated Cell Lysis. The Journal of Immunology. 182(6). 3510–3521. 144 indexed citations

11.

Hamaï, Ahmed, Franck Meslin, Houssem Benlalam, et al.. (2008). ICAM-1 Has a Critical Role in the Regulation of Metastatic Melanoma Tumor Susceptibility to CTL Lysis by Interfering with PI3K/AKT Pathway. Cancer Research. 68(23). 9854–9864. 61 indexed citations

12.

Jacques, Nathalie, Nadège Vimond, Rosa Conforti, et al.. (2008). Quantification of circulating mature endothelial cells using a whole blood four-color flow cytometric assay. Journal of Immunological Methods. 337(2). 132–143. 40 indexed citations

13.

Geoerger, Birgit, Nathalie Gaspar, Paule Opolon, et al.. (2008). EGFR tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenografts. International Journal of Cancer. 123(1). 209–216. 38 indexed citations

14.

Albagli, Olivier, Yann Lécluse, Philippe Pognonec, Kim E. Boulukos, & Patrick Martin. (2007). A new generation of pPRIG-based retroviral vectors. BMC Biotechnology. 7(1). 85–85. 19 indexed citations

15.

Chansac, Béatrice Le Maux, Alessandro Moretta, Isabelle Vergnon, et al.. (2005). NK Cells Infiltrating a MHC Class I-Deficient Lung Adenocarcinoma Display Impaired Cytotoxic Activity toward Autologous Tumor Cells Associated with Altered NK Cell-Triggering Receptors. The Journal of Immunology. 175(9). 5790–5798. 65 indexed citations

16.

Geoerger, Birgit, Victor W. van Beusechem, Paule Opolon, et al.. (2005). Expression of p53, or targeting towards EGFR, enhances the oncolytic potency of conditionally replicative adenovirus against neuroblastoma. The Journal of Gene Medicine. 7(5). 584–594. 23 indexed citations

17.

Ugo, Valérie, Christophe Marzac, Irène Teyssandier, et al.. (2004). Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera. Experimental Hematology. 32(2). 179–187. 127 indexed citations

18.

Geoerger, Birgit, Jacques Grill, Paule Opolon, et al.. (2003). Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts. British Journal of Cancer. 89(3). 577–584. 67 indexed citations

19.

Lécluse, Yann, et al.. (2002). Bloom's syndrome protein response to ultraviolet-C radiation and hydroxyurea-mediated DNA synthesis inhibition. Oncogene. 21(13). 2079–2088. 33 indexed citations

20.

Lorain, Stéphanie, Jean‐Pierre Quivy, Christine Scamps, et al.. (1998). Core Histones and HIRIP3, a Novel Histone-Binding Protein, Directly Interact with WD Repeat Protein HIRA. Molecular and Cellular Biology. 18(9). 5546–5556. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact